Drug Trial Radar · NCT00785291
Paclitaxel, Nab-paclitaxel, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer
Last checked: Nov 19, 2026Latest source record: Jun 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
799
Actual
Start
Oct 13, 2008
Primary completion
Dec 31, 2013
Study completion Jun 15, 2017
Sponsor
- Lead sponsor
- National Cancer Institute (NCI)NIH
- Sponsor type
- NIH
- First posted
- Nov 5, 2008
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This randomized phase III trial studies the side effects and how well different chemotherapy regimens with or without bevacizumab work in treating patients with stage IIIC or stage IV breast cancer. Drugs used in chemotherapy, such as paclitaxel, paclitaxel albumin-stabilized nanoparticle formulation (nab-paclitaxel), and ixabepilone, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Bevacizumab may block tumor growth by targeting certain cells and slowing the growth of blood vessels to the tumor. It is not yet known which treatment regimen is more effective in treating patients with breast cancer.
Conditions
- Estrogen Receptor Negative
- Estrogen Receptor Positive
- HER2/Neu Negative
- HER2/Neu Positive
- Progesterone Receptor Negative
- Progesterone Receptor Positive
- Recurrent Breast Carcinoma
- Stage IIIC Breast Cancer AJCC v6
- Stage IV Breast Cancer AJCC v6 and v7
Interventions
BevacizumabBiological
Given IV
IxabepiloneDrug
Given IV
Laboratory Biomarker AnalysisOther
Correlative studies
Nab-paclitaxelDrug
Given IV
PaclitaxelDrug
Given IV
Questionnaire AdministrationOther
Ancillary studies
Primary outcomes
What the sponsor says the trial is designed to measure.
- Progression Free SurvivalTime frame: Time from randomization to progression or death due to any cause, whichever occurs first (up to 5 years)
Locations
704 sites in 2 countries. Site status is shown where the registry gives one.
Mayo Clinic in Arizona
Scottsdale, Arizona
Sparks Regional Medical Center
Fort Smith, Arkansas
Mercy Hospital Fort Smith
Fort Smith, Arkansas
NEA Baptist Memorial Hospital
Jonesboro, Arkansas
Kaiser Permanente-Anaheim
Anaheim, California
Kaiser Permanente-Deer Valley Medical Center
Antioch, California
PCR Oncology
Arroyo Grande, California
Kaiser Permanente-Baldwin Park
Baldwin Park, California
Kaiser Permanente-Bellflower
Bellflower, California
Alta Bates Summit Medical Center-Herrick Campus
Berkeley, California
Providence Saint Joseph Medical Center/Disney Family Cancer Center
Burbank, California
Mills-Peninsula Medical Center
Burlingame, California
East Bay Radiation Oncology Center
Castro Valley, California
Eden Hospital Medical Center
Castro Valley, California
Valley Medical Oncology Consultants-Castro Valley
Castro Valley, California
City of Hope Comprehensive Cancer Center
Duarte, California
Bay Area Breast Surgeons Inc
Emeryville, California
Kaiser Permanente-Fontana
Fontana, California
Kaiser Permanente-Fremont
Fremont, California
Valley Medical Oncology Consultants-Fremont
Fremont, California
Kaiser Permanente-Fresno
Fresno, California
Marin Cancer Care Inc
Greenbrae, California
Marin General Hospital
Greenbrae, California
Kaiser Permanente - Harbor City
Harbor City, California
Kaiser Permanente-Irvine
Irvine, California
Loma Linda University Medical Center
Loma Linda, California
Kaiser Permanente Los Angeles Medical Center
Los Angeles, California
Kaiser Permanente West Los Angeles
Los Angeles, California
Contra Costa Regional Medical Center
Martinez, California
El Camino Hospital
Mountain View, California
Sutter Cancer Research Consortium
Novato, California
Highland General Hospital
Oakland, California
Alta Bates Summit Medical Center - Summit Campus
Oakland, California
Bay Area Tumor Institute
Oakland, California
Hematology and Oncology Associates-Oakland
Oakland, California
Tom K Lee Inc
Oakland, California
Kaiser Permanente-Oakland
Oakland, California
Kaiser Permanente - Panorama City
Panorama City, California
Valley Care Health System - Pleasanton
Pleasanton, California
Valley Medical Oncology Consultants
Pleasanton, California
Showing 40 of 704 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.